Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1529
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Open J Gate
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Mesenchymal stem cell as a cure for brain damage induced by chronic Toxocara canis infection in an experimental mouse model
6th Annual Conference on Parasitology & Infectious Diseases
Fatma Hamed Shalan, Ayman Abd El-Moenem Elbadry, Amera Fathy Afifi, Engy Victor Nassief Beshay, Samar Ahmed El-Refai, Hala Gabr Metwaly,Eman Ahmedy, Eman Abd El-Fattah Badr, Dalia Refaat Al-Sharaky and Gehan Salah Sadek
Parasitology Department, Faculty of Medicine, Menoufia University, EgyptParasitology Department, Faculty of Medicine, Cairo University, EgyptClinical Pathology Department, Faculty of Medicine, Cairo University, EgyptClinical Pathology Department, Faculty of Medicine, Menoufia University, EgyptBiochemistry Department, Faculty of Medicine, Menoufia University, EgyptPathology Department, Faculty of Medicine, Menoufia University, Egypt
ScientificTracks Abstracts: J Infect Dis Ther
Abstract
Neurotoxocariasis is a serious condition linked to the reduced cognitive function in children and some neurodegenerative diseases. Unfortunately, the available drugs for its treatment are with variable results. Mesenchymal stem cells (MSCs) have been used in experimental and clinical trials and it gave promising therapeutic results. Therefore, this study was designed using forty T. canis-infected albino mice (1000 eggs/mouse, orally) and a control group (GI) of ten healthy mice. The infected groups were GII: infected non-treated (control group), GIII: albendazole-treated (100 mg/kg/d once orally for 5 successive days), GIV: MSCs-treated (3 x 106 MSCs in 0.1 mL of PBS via the tail vein) and GV: albendazole + MSCs-treated. Treatment was commenced 6 weeks p.i. and the experiment was terminated four weeks after treatment. The brain tissue of each mouse was subjected for histopathological, immunohistochemical studies (caspase-3, TGF-β), detection or T. canis DNA by real-time PCR and gene expression the biomarkers of brain damage (S100B, GFAP) by RT-PCR. Moreover, homing of iron oxide-labelled MSCs in brain tissues was assessed by Prussian blue stain. The brain tissues of GII showed numerous T. canis larvae, significant congestion, thickening of arterioles, inflammatory infiltrate and gliosis associated with marked immunohistochemical expression of TGF-β and caspase-3 as well as marked S100B and GFAP gene expression. Significant improvements of the previous parameters and T. canis DNA were recorded in all the treated groups. However, the best results were obtained with combined albendazole + MSCs therapy. Thus, MSCs could be considered in the treatment of chronic neurotoxocariasis.Biography
Fatma shalan has completed her bachelor of medicine with excellent grade in 2006 from Faculty of Medicine, Menofia University. She has completed her M.Sc. in Medical Parasitology in 2012. Her thesis was about the relationship between IL-6 and some parasitic infections in hepatic patients in Menofia governorate. This abstract is representative of her M.D. thesis.
E-mail: dr.fatma.shaalan@gmail.com
